GEN Exclusives

More »

GEN News Highlights

More »
Sep 23, 2008

Tris Finishes 15,000 Sq. Ft. Expansion

  • Tris Pharma says that its facility expansion in South Brunswick, NJ, is complete. The company reports successful clearance of FDA preapproval inspection.

    The expansion provides approximately 15,000 sq. ft. of additional space to the company's premises and FDA-compliant cGMP facility.

    It allows for additional commercial-scale equipment and a larger warehouse that frees up space for a high-speed packaging area. “FDA's assurance of our facilities and the recent investment in our capabilities means we have ample infrastructure with which to leverage our exciting pipeline of drug delivery technologies and services,” says Ketan Mehta, CEO and founder of Tris Pharma.

    Through its pharma partners, Tris reports that it has more than 30 products in development, submission, or on the market. The firm specializes in controlled-release dosage forms for liquid, solid, and orally disintegrating tablets as well as enhancing bioavailability of poorly absorbed drugs.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »